Superior Survival in Non-Hodgkin Lymphoma Following Autologous Stem Cell Transplantation with Intravenous Busulfan, Cyclophosphamide, and Etoposide

被引：0
|
作者：
Dean, Robert [1 ]
Rybicki, Lisa [2 ]
Pohlman, Brad [1 ]
Sweetenham, John William [1 ]
Smith, Stephen [1 ]
Copelan, Edward [1 ]
Sobecks, Ronald [1 ]
Kalaycio, Matt [1 ]
Andresen, Steven [1 ]
Sungren, Shawnda [1 ]
Bolwell, Brian J. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：762 / 763
页数：2
相关论文
共 50 条
  • [1] Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide
    Dean, Robert M.
    Pohlman, Brad
    Sweetenham, John W.
    Sobecks, Ronald M.
    Kalaycio, Matt E.
    Smith, Stephen D.
    Copelan, Edward A.
    Andresen, Steven
    Rybicki, Lisa A.
    Curtis, Julie
    Bolwell, Brian J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (02) : 226 - 234
  • [2] A NOVEL PREPARATORY REGIMEN INCLUDING BUSULFAN, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR AUTOLOGOUS TRANSPLANTATION IN HODGKIN AND NON-HODGKIN LYMPHOMA AND MULTIPLE MYELOMA
    EACopelan
    BBolwell
    JLKlien
    NKapoor
    BRAvalos
    ChineseMedicalJournal, 1994, (10)
  • [3] A NOVEL PREPARATORY REGIMEN INCLUDING BUSULFAN, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR AUTOLOGOUS TRANSPLANTATION IN HODGKIN AND NON-HODGKIN LYMPHOMA AND MULTIPLE MYELOMA
    EACopelan
    BBolwell
    JLKlien
    NKapoor
    BRAvalos
    中华医学杂志(英文版), 1994, (10) : 8 - 8
  • [4] Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
    Copelan, EA
    Penza, SL
    Pohlman, B
    Avalos, BR
    Goormastic, M
    Andresen, SW
    Kalaycio, M
    Bechtel, TP
    Scholl, MD
    Elder, PJ
    Ezzone, SA
    O'Donnell, LC
    Tighe, MB
    Risley, GL
    Young, DC
    Bolwell, BJ
    BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1243 - 1248
  • [5] Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
    EA Copelan
    SL Penza
    B Pohlman
    BR Avalos
    M Goormastic
    SW Andresen
    M Kalaycio
    TP Bechtel
    MD Scholl
    PJ Elder
    SA Ezzone
    LC O'Donnell
    MB Tighe
    GL Risley
    DC Young
    BJ Bolwell
    Bone Marrow Transplantation, 2000, 25 : 1243 - 1248
  • [6] Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma
    Kim, Kyoung Ha
    Kim, Won Seog
    Kim, Seok Jin
    Yoon, Dok Hyun
    Suh, Cheolwon
    Kang, Hye Jin
    Choi, Chul Won
    Lee, Ho Sup
    Bae, Sung Hwa
    Park, Jinny
    Park, Eun Kyung
    Kwak, Jae-Yong
    Lee, Mark Hong
    Kang, Byung Woog
    Park, Sung-Kyu
    Won, Jong-Ho
    TRANSPLANT INTERNATIONAL, 2020, 33 (10) : 1211 - 1219
  • [7] Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin's lymphoma patients
    Bicim, Soykan
    Erkurt, Mehmet Ali
    Kuku, Irfan
    Kaya, Emin
    Berber, Ilhami
    Kaya, Ahmet
    Hidayet, Emine
    Uysal, Ayse
    Sarici, Ahmet
    Ozen, Ilknur Nizam
    IRAQI JOURNAL OF HEMATOLOGY, 2024, 13 (01) : 1 - 6
  • [8] Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma
    Cote, Gregory M.
    Hochberg, Ephraim P.
    Muzikansky, Alona
    Hochberg, Fred H.
    Drappatz, Jan
    McAfee, Steven L.
    Batchelor, Tracy T.
    LaCasce, Ann S.
    Fisher, David C.
    Abramson, Jeremy S.
    Armand, Philippe
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : 76 - 83
  • [9] Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    J G Kim
    S K Sohn
    Y S Chae
    D H Yang
    J-J Lee
    H-J Kim
    H J Shin
    J S Jung
    W S Kim
    D H Kim
    C Suh
    S J Kim
    H-S Eom
    S H Bae
    Bone Marrow Transplantation, 2007, 40 : 919 - 924
  • [10] Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Kim, J. G.
    Sohn, S. K.
    Chae, Y. S.
    Yang, D. H.
    Lee, J-J
    Kim, H-J
    Shin, H. J.
    Jung, J. S.
    Kim, W. S.
    Kim, D. H.
    Suh, C.
    Kim, S. J.
    Eom, H-S
    Bae, S. H.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 919 - 924
12345